AngioDynamics Reports Fiscal 2021 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
AngioDynamics (ANGO) Tops Q1 EPS by 9c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus
September 29, 2020 7:03 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.02, $0.09 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $70.2 million versus the consensus estimate of $65.1 million.
Fiscal 2021 First Quarter Highlights
Net sales of $70.2 million increased 6.3% compared to the prior-year quarter, inclusive of the previously disclosed $5.2 million order from the National Health Service (NHS) in the UKGross margin... More